Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX: PBT) covers the month of November 2006. The document reports the results of the company's Annual General Meeting (AGM) held on November 30, 2006. The registrant is a foreign private issuer based in South Melbourne, Victoria, Australia.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance data.
Material Changes and Voting Results
All resolutions presented at the AGM were duly carried on a show of hands. Key voting outcomes included:
- Director Re-election: Prof. Colin Masters was re-elected as a Director with 27,270,563 votes in favor versus 4,064,660 against.
- Equity Grants: Shareholders approved the grant of unquoted options to six individuals: Mr. Geoffrey Kempler, Prof. Colin Masters, Mr. Brian Meltzer, Mr. George Mihaly, Mr. Peter Marks, and Mr. Richard Revelins. All option grants received majority support, with "For" votes ranging from approximately 24.9 million to 25.9 million.
- Corporate Actions: Shareholders approved a prior issue of securities to a consultant and a change of auditor. The adoption of the Remuneration Report was also approved on a non-binding basis.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves strictly as a notice of the AGM results.
Key Facts for Investor Verification
- Verify the specific terms and vesting schedules of the unquoted options granted to executives and directors, as the filing only confirms approval.
- Confirm the identity of the new auditor following the approved change of auditor resolution.
- Review the details of the prior issue of securities to the consultant to understand the dilution impact.
- Note that the company operates under the ASX ticker PBT and is headquartered in Australia.